Stagezero Life Sciences Ltd (SZLSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Sales | 3,795 | 5,068 | 4,152 | 139 | 186 |
| Cost of Goods | 4,199 | 3,891 | 3,456 | 1,100 | 1,265 |
| Gross Profit | -404 | 1,178 | 696 | -961 | -1,079 |
| Operating Expenses | 7,542 | 10,031 | 4,888 | 4,279 | 3,853 |
| Operating Income | -7,747 | -7,963 | -3,737 | -5,140 | -4,667 |
| Interest Expense | 284 | 1,436 | 664 | 803 | 578 |
| Other Income | -3,385 | 1,915 | -2,463 | 2,462 | 1,552 |
| Pre-tax Income | -11,415 | -7,484 | -6,864 | -3,482 | -3,693 |
| Net Income Continuous | -11,415 | -7,484 | -6,864 | -3,482 | -3,693 |
| Net Income | $-11,415 | $-7,484 | $-6,864 | $-3,482 | $-3,693 |
| EPS Basic Total Ops | -0.11 | -0.11 | -0.15 | -0.16 | -0.16 |
| EPS Basic Continuous Ops | -0.11 | -0.11 | -0.15 | -0.13 | -0.22 |
| EPS Diluted Total Ops | -0.11 | -0.11 | -0.15 | -0.16 | -0.16 |
| EPS Diluted Continuous Ops | -0.11 | -0.11 | -0.15 | -0.13 | -0.22 |
| EPS Diluted Before Non-Recurring Items | -0.11 | -0.21 | -0.12 | -0.16 | N/A |
| EBITDA(a) | $-7,507 | $-7,652 | $-3,482 | $-4,842 | $-4,057 |